Evidence map›Paper›PMID 39341155›Full record

ArticleEBioMedicine2024

Identification and analysis of microplastics in para-tumor and tumor of human prostate.

Chenyao Deng, Jun Zhu, Zishui Fang, Yuzhuo Yang, Qiancheng Zhao, Zhe Zhang, Zirun Jin, Hui Jiang

Abstract read
In one paragraph

Article in EBioMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Health impacts of micro- and nanoplastics in humans: systematic review of in vivo evidence.Environmental health : a global access science source · 2026
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenyao DengDepartment of Urology, Peking University First Hospital, Beijing, 100034, China; The Institution of Urology, Peking University, Beijing, 100034, China; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China; National Urological Cancer Center, Beijing, 100034, China.
Jun ZhuDepartment of Urology, Peking University First Hospital, Beijing, 100034, China; The Institution of Urology, Peking University, Beijing, 100034, China; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China; National Urological Cancer Center, Beijing, 100034, China.
Zishui FangDepartment of Urology, Peking University First Hospital, Beijing, 100034, China; The Institution of Urology, Peking University, Beijing, 100034, China; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China; National Urological Cancer Center, Beijing, 100034, China.
Yuzhuo YangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, 100034, China.
Qiancheng ZhaoDepartment of Urology, Peking University First Hospital, Beijing, 100034, China; The Institution of Urology, Peking University, Beijing, 100034, China; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China; National Urological Cancer Center, Beijing, 100034, China.
Zhe ZhangDepartment of Urology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, 100191, China.
Zirun JinDepartment of Urology, Peking University First Hospital, Beijing, 100034, China; The Institution of Urology, Peking University, Beijing, 100034, China; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China; National Urological Cancer Center, Beijing, 100034, China. Electronic address: jinzirun@bjmu.edu.cn.
Hui JiangDepartment of Urology, Peking University First Hospital, Beijing, 100034, China; The Institution of Urology, Peking University, Beijing, 100034, China; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China; National Urological Cancer Center, Beijing, 100034, China. Electronic address: jianghui@bjmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile microplastics are widely found in various human organs and tissues, the relationship between microplastics and human health, especially prostate health, remains unclear. This study aims to identify and quantify the properties, types, and abundance of microplastics in paired para-tumor and tumor tissues of human prostate. Additionally, the potential correlation between microplastics abundance and prostate cancer are investigated.

methodsPaired para-tumor and tumor samples of the prostate were collected from 22 patients who underwent robot-assisted radical prostatectomy. A combination of laser direct infrared spectroscopy, scanning electron microscopy and pyrolysis-gas chromatography-mass spectrometry was utilized to analyse the properties, type and abundance of microplastics. Correlations between microplastics abundance, demographic characteristics and clinical features of patients were also examined.

findingsLaser direct infrared analysis revealed the presence of microplastics, including polyamide, polyethylene terephthalate, and polyvinyl chloride, in both para-tumor and tumor tissues of human prostate. However, polystyrene was exclusively detected in tumor tissues. The particle size distribution in the prostate tissue mainly ranged from 20 to 100 μm. Approximately 31.58% of para-tumor samples exhibited sizes between 20 and 30 μm, while 35.21% of tumor samples displayed sizes between 50 and 100 μm. The shapes of these microplastics varied considerably with irregular forms being predominant. Additionally, microplastics were detected by pyrolysis-gas chromatography-mass spectrometry in 20 paired prostate tissues. The mean abundance of microplastics was found to be 181.0 μg/g and 290.3 μg/g in para-tumor and tumor of human prostate samples, respectively. Among the 11 target types microplastics polymers, only polystyrene, polypropylene, polyethylene, and polyvinyl chloride were detected. Notably, polystyrene, polyethylene, and polyvinyl chloride, except for polypropylene, demonstrated significantly higher abundance in tumor tissues compared to their respective paired para-tumor. Furthermore, a positive correlation was observed between polystyrene abundance in the tumor samples of human prostate and frequency of take-out food consumption.

interpretationThis research provides both qualitative and quantitative evidence of the microplastics presence as well as their properties, types, and abundance in paired para-tumor and tumor samples of human prostate. Correlations between microplastics abundance, demographics, and clinical characteristics of patients need to be further validated in future studies with a larger sample size.

fundingThis work was supported by the National Key Research and Development Program of China (2022YFC2702600) and the National Natural Science Foundation of China (Grant No. 82071698, No. 82101676, and No. 82271630).

Indexed as

MicroplasticsProstatic NeoplasmsAgedGas Chromatography-Mass SpectrometryHumansMaleMiddle AgedProstateProstatectomyMicroplasticsLaser direct infrared spectroscopyMicroplasticsProstate cancerPyrolysis–gas chromatography-mass spectrometryScanning electron microscopy

Identifiers

PMID39341155
PMCPMC11481604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.